10X Genomics, Inc. (TXG)
63.16
+1.51
(+2.45%)
USD |
NASDAQ |
Sep 03, 16:00
63.48
+0.32
(+0.51%)
After-Hours: 18:28
10X Genomics Cash from Investing (Quarterly) : -7.735M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.735M |
| March 31, 2026 | -1.311M |
| December 31, 2025 | -1.805M |
| September 30, 2025 | -8.801M |
| June 30, 2025 | -0.939M |
| March 31, 2025 | -1.893M |
| December 31, 2024 | -51.59M |
| September 30, 2024 | -3.618M |
| June 30, 2024 | 11.95M |
| March 31, 2024 | 10.63M |
| December 31, 2023 | 13.10M |
| September 30, 2023 | 4.90M |
| June 30, 2023 | -4.462M |
| March 31, 2023 | 119.96M |
| Date | Value |
|---|---|
| December 31, 2022 | -33.17M |
| September 30, 2022 | -32.63M |
| June 30, 2022 | -27.53M |
| March 31, 2022 | -257.56M |
| December 31, 2021 | -27.62M |
| September 30, 2021 | -20.23M |
| June 30, 2021 | -14.57M |
| March 31, 2021 | -44.32M |
| December 31, 2020 | -22.27M |
| September 30, 2020 | -1.31M |
| June 30, 2020 | -6.739M |
| March 31, 2020 | -8.079M |
| December 31, 2019 | -6.581M |
| September 30, 2019 | -13.68M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Twist Bioscience Corp. | -10.20M |
| Alamar Biosciences, Inc. (California) | -120.80M |
| Personalis, Inc. | 38.16M |
| Adaptive Biotechnologies Corp. | -43.48M |
| Tempus AI, Inc. | -11.09M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 16.97M |
| Cash from Financing (Quarterly) | 3.016M |
| Free Cash Flow | 121.44M |
| Free Cash Flow Per Share (Quarterly) | 0.1184 |
| Free Cash Flow to Equity (Quarterly) | 17.98M |
| Free Cash Flow to Firm (Quarterly) | 15.39M |
| Free Cash Flow Yield | 1.51% |